Offer void where prohibited by law and subject to change or discontinue without notice. There were no studies done with Basaglar in these groups of children. = Basaglar® (insulin glargine injection) 100 units/mL. ABASAGLAR deve essere somministrato una volta al giorno, a qualsiasi ora del giorno ma sempre alla stessa ora ogni giorno. Lantus vs Basaglar: Lantus and Basaglar are both insulin glargine prescribed to treat patients with type 1 and type 2 diabetes. Basaglar ® (insulin glargine injection) 100 units/mL. Diabetes patients in the United Kingdom can now access Abasaglar, a new form of insulin glargine, after it was launched last week. By clicking "I Agree" you consent to our use of tracking technologies and disclosure of tracking data to third party ad networks or social media companies for the purposes above. In uno studio, Abasaglar è stato confrontato con Lantus in aggiunta a una terapia a base di insulina a breve durata d'azione in 536 pazienti con diabete di tipo 1. Before injecting your BasaglarYou can inject Basaglar yourself, or you can have a trained caregiver inject it for you. Abasaglar là một loại thuốc có chứa hoạt chất insulin glargine . | © Lilly USA, LLC 2021. See what insulin is and how it may help people with type 2 diabetes. The Basaglar prefilled pen is a disposable insulin delivery device for use by a single patient to inject Basaglar. Print Full Prescribing Information. http://www.diabetes.org/living-with-diabetes/treatment-and-care/blood-glucose-control/a1c/?loc=lwd-slabnav. Make sure you or your caregiver: Staying safe while taking your BasaglarTo stay safe while taking Basaglar, be sure you only use Basaglar that is clear and colorless and does not have any particles.Be sure you do not: For more information, call 1-800-545-5979 or go to Basaglar.com. Abasaglar là một loại thuốc "sinh học". Offer subject to a monthly cap of $150 and a separate $1800 maximum annual cap. You or the other person can get a serious infection. twice-daily NPH insulin. Abasaglar (Insulina Glargine) è un farmaco che serve per curare le seguenti malattie: . It is used to control high blood sugar in: It is not known if Basaglar is safe and effective in children with type 2 diabetes or in children younger than 6 years with type 1 diabetes. For more information about Lilly’s privacy practice and to manage third-party preferences, click here. may He or she may also tell you to change your dose because of other medicines you take. Facebook It is used in adults and children over the age of two for the treatment of diabetes. Sanofi is the manufacturer of Lantus. Nó được chỉ định trong điều trị bệnh tiểu đường ở người lớn và trẻ em từ hai tuổi. Do not change the insulin you use or your dose, unless your doctor tells you to. Az ABASAGLAR adagolási rendjét (az adagot és a beadás időpontját) egyénileg kell megállapítani. Understanding A1C: A1C does it all. Indianapolis, IN: Eli Lilly and Company; This site is intended for use by US residents aged 18 or older. If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us. Please select the therapeutic area you would like to see more about. All rights reserved. Accessed February 27, 2020. symptoms of low blood sugar (hypoglycemia), an allergy to Basaglar or any of its ingredients, extreme drowsiness, dizziness, or confusion, minor reactions where you have injected Basaglar, changes in fat tissue where you have injected Basaglar. PP-BV-US-0931 12/2020 ©Lilly USA, LLC 2020. Trattamento del diabete mellito in adulti, adolescenti e bambini a partire dai 2 anni di età. every evening, for a daily total of 50 units of NPH insulin, Transitioning From Another Basal Insulin to Basaglar Therapy1, Then, To activate a savings card, just answer the following eligibility questions. American Diabetes Association. BASAGLAR® (insulin glargine injection): Transitioning From Insulin Degludec, BASAGLAR® (insulin glargine injection): Dose Initiation and Titration, BASAGLAR® (insulin glargine injection): Transitioning From Insulin Detemir, BASAGLAR® (insulin glargine injection) 100 Units/mL: Initiation of Therapy. It is used to control high blood sugar in: It is not known if Basaglar is safe and effective in children with type 2 diabetes or in children younger than 6 years with type 1 diabetes. Figure 1. Insulin glargine from competitor Eli Lilly became available in most countries during 2015, under the brand names Basaglar (as a follow-on in the US) and Abasaglar (as a biosimilar in the EU). Talk with your doctor about low blood sugar and how to manage it. From Another Basal Insulin to Basaglar Therapy). We encourage you to read the privacy policy of every Web site you visit.Click "Continue" to proceed or "Return" to return to LillyMedical.com. 25 Wondering about your routine with insulin? You or the other person can get a serious infection. This will help you make sure that you are using the correct insulin. Or you can The BASAGLAR Savings Card may help with the cost of your prescription. 1. Basaglar is a long-acting insulin that is only available with a prescription. These long-acting insulins are very similar, but they are not interchangeable. INDICATION Basaglar is a long-acting insulin that is only available with a prescription. Your email address will not be saved or stored. We encourage you to read the privacy policy of every website you visit. If changing patients from a once-daily insulin glargine product, 300 units/mL, to once-daily BASAGLAR, the recommended initial BASAGLAR dosage is 80% of the insulin glargine product, 300 units/mL, dose that is being discontinued. It’s normal to have a lot of questions when starting insulin. You are now leaving the LillyMedical.com Web site. Abasaglar has been developed by Eli Lilly and Boehringer Ingelheim and will directly compete […] National Institute of Diabetes and Digestive and Kidney Diseases. To avoid medication errors between BASAGLAR and other insulins, instruct patients to always check the insulin label before each injection. Insulin Glargine is a sterile solution of insulin glargine for use as a subcutaneous injection. It is not known if Basaglar may harm your unborn or breastfeeding baby. 2. What Is Basaglar? ABASAGLAR deve essere somministrato una volta al giorno, a qualsiasi ora del giorno ma sempre alla stessa ora ogni giorno. Abasaglar (Insulina Glargine): sicurezza e modo d’azione. This could cause low or high blood sugar, which could be serious. Accidental mix-ups between another insulin glargine product (100 units/mL) and other insulins, particularly rapid-acting insulins, have been reported. insulins will lower the likelihood of hypoglycemia.1, Table This means that Abasaglar is similar to a biological medicine (also known as the ‘reference medicine’) that is already authorised in the European Union (EU). En un estudio, Abasaglar se comparó con Lantus además de la terapia de corta duración basada en insulina en 536 pacientes con diabetes tipo 1. En estos pacientes, la HbA1c antes del tratamiento fue de un promedio de 7, 8%, mientras que la caída de 6 meses fue similar (0, 35% en el grupo de Abasaglar y 0, 46% en el grupo de Lantus). The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Diabetes is a disease in which the body does not produce enough insulin to control the level of blood glucose. Whether you and your doctor are still discussing insulin or you’ve already been prescribed BASAGLAR, you’ve come to the right place. Lilly USA, LLC is not responsible for the privacy policy of any third-party Web sites. All rights reserved. 1. Product overview. This information does not take the place of talking with your doctor. Abasaglar is a medicine that contains the active substance insulin glargine. 1, 2. Reductions in the Basaglar dose when transitioning from certain ABASAGLAR should be administered once daily at any time but at the same time each day. is Il regime posologico di ABASAGLAR (dose e tempi della somministrazione) deve essere aggiustato individualmente. Use a new needle for each injection.  about any other prescription medicines you take, especially ones called TZDs. GoodStart® is a registered trademark of Pleio, Inc. beginsulin® is a trademark of Eli Lilly and Company. The information contained in this section of basaglar.com is intended for US Healthcare providers. 2018. differ from the prior basal insulin dose and other concomitant 1-800-LILLYRX 1-800-545-5979. ©Lilly USA, LLC 2020. Available Mon - Fri, 9am - 7pm EST. Do not inject your insulin into the exact same spot or where the skin has pit or lumps. This dosage reduction will lower the likelihood of hypoglycemia [see Warnings and Precautions ]. We’ll explain how to use BASAGLAR, ways you can establish a good routine, where to inject, and more. Abasaglar ® (basal insulin glargine) Print This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. The possible serious side effects of Basaglar are: The most common side effects of Basaglar are: These are not all of the possible side effects. Eli Lilly … 25 units of NPH insulin every morning and 25 units of NPH insulin every evening, for a daily total of 50 units of NPH insulin, transitions to 40 units of Basaglar once daily. 1. Diabetes mellitus is a disease where your body does not produce enough insulin to control the level of blood sugar. Avoid injecting into thickened, tender, bruised, scaly, hard, or damaged skin. symptoms of low blood sugar (hypoglycemia) or. drive or use heavy machinery until you know how Basaglar affects you. If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979). This can help reduce your chance of getting pits, lumps, or thickened skin where you inject your insulin. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Read the Instructions for Use that come with your Basaglar prefilled pen. Call Us. Basaglar (insulin glargine injection) is a long-acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.What Are Side Effects of Basaglar? Medicamentul se utilizează la adulţi şi copii cu vârsta peste doi ani pentru tratamentul diabetului. This offer is invalid for patients without commercial drug insurance or those whose prescription claims are eligible to be reimbursed, in whole or in part, by any governmental program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medigap, DOD, VA, TRICARE®/CHAMPUS, or any state patient or pharmaceutical assistance program. is 80% of the total daily NPH insulin dosage. Basaglar Abasaglar este un medicament „biosimilar”. Insulin glargine biosimilar (Abasaglar) is licensed for the treatment of diabetes mellitus in adults, young people and children over 2 years. Then your card will be ready to be shared with your specialty pharmacy. BASAGLAR ® (insulin glargine injection) 100 units/mL is your beginsulin ® In patients with type 1 diabetes, BASAGLAR must be used with mealtime insulin. an intermediate- or long-acting insulin other than Lantus. 2zm8cx04rz - insulin glargine Η ινσουλίνη glargine (insulin glargine) έχει μακρύτερη διάρκεια της δράσης, σχετίζεται άμεσα με το βραδύτερο ρυθμό απορρόφησής της … Il regime posologico di ABASAGLAR (dose e tempi della somministrazione) deve essere aggiustato If your doctor decides to give your child Basaglar, he or she may give you special instructions. BASAGLAR® Insulin glargine biosimilar (Abasaglar) is licensed for the treatment of diabetes mellitus in adults, young people and children over 2years. 80% of the total daily NPH insulin dosage. This could cause low or high blood sugar, which could be serious. Your doctor may tell you to change your dose because of illness, increased stress, or changes in your weight, diet, or level of physical activity or exercise. See Prescribing Information above, if applicable. Basaglar® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates. intermediate- or long-acting insulin other than Lantus. References1. You can report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch. drink alcohol or use other medicines that contain alcohol when taking Basaglar. Patient must have commercial drug insurance with insurance provider coverage for BASAGLAR to pay as little as $5 for 5 BASAGLAR KwikPens (1 carton). 2-es típusú diabetes mellitus-ban szenvedő betegek esetén az ABASAGLAR oralis antidiabetikumokkal együtt is adható. See what insulin is and how it may help people with type 2 diabetes. Abasaglar is a medicine that contains the active substance insulin glargine. Abasaglar® KwikPen® 2. Insulin glargine is a recombinant human insulin analogue that is a long-acting (up to 24-hour duration of action), parenteral blood glucose lowering agent. antihyperglycemic medications may need to be adjusted. Be sure to talk to your doctor or other health care provider about Basaglar and how to take it. therapy, the recommended initial dose of Basaglar is based on the | © Lilly USA, LLC 2021. Abbreviations: Twitter Basaglar is not used to treat diabetic ketoacidosis. Accessed February 27, 2020. 2. transitions to 40 units of Basaglar once daily, an Abasaglar is a ‘biosimilar medicine’. Insulin glargine biosimilar is licensed for the treatment of diabetes mellitus in adults, young people and children over 2 years.Abasaglar is a basal insulin for once daily use and is bioequivalent to insulin glargine ().Abasaglar is available as cartridges of 100 units/ml for use in the reusable pen or as a pre‑filled Abasaglar pen 100 units/ml. transitioning patients from another basal insulin to Basaglar Abasaglar este o insulina de substitutie foarte asemanatoare cu insulina produsa de organism. It has yet to be considered in the Local medicines decision making process, guidance for use with defined patient criteria is pending. Remember, Lantus and Levemir start with an ‘L’ for long acting. Az ABASAGLAR-t naponta egyszer kell beadni, bármikor a nap folyamán, de minden nap ugyanabban az időpontban. We can use the names of the insulin to get an idea of the type of insulin it might be. Resources may contain information about doses, uses, formulations and populations different from product labeling. BASAGLAR goes beyond just insulin by offering support you may need. About the Data These secondary analyses evaluated the efficacy and safety of ABASAGLAR compared to Lantus insulin glargine in a subgroup of patients who reported pre-study treatment with Lantus insulin glargine in two prospective, global, Phase III, parallel, randomised studies: ELEMENT-1, a 52-week open-label study in people with type 1 diabetes, and ELEMENT-2, a 24-week … Lantus 100 unit / ml solution for injection . Abasaglar is available as cartridges of 100units/ml for Insulin Glargine is produced by recombinant DNA technology.  if you are pregnant, breastfeeding, or plan to become pregnant. The reference medicinal product has been marketed in the European Union for over 10 years. the recommended initial dose of Basaglar…, 50 Your doctor is the best person to help you decide if Basaglar is right for you. From Another Basal Insulin to Basaglar Therapy, If This is a modified insulin, very similar to human insulin. Check out our resources designed to help you start basal insulin therapy, support that may help you save on BASAGLAR, and contacts for additional support. SELECT SAFETY INFORMATIONWarningsDo not take Basaglar if you have: Your doctor recommended BASAGLAR because it’s a long-acting insulin, which means it’s a good place to begin for people new to insulin. Lantus = Lantus® (insulin glargine injection) 100 units/mL; Check your insulin label each time you give your injection. If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us. ABASAGLAR e Toujeo (insulina glargine 300 unità/mL) non sono bioequivalenti e non sono direttamente intercambiabili. There were no studies done with Basaglar in these groups of children. You can get a serious infection or the wrong dose of insulin if you re-use needles. Your Savings Card has been delivered and is ready to use. This can happen even if you change the needle. *Offer good until 12/31/2021 for up to 24 prescriptions. Prin controlul nivelului glucozei din sange, se reduc simptomele si complicatiile diabetului. Abasaglar - insulin glargine được sử dụng là gì và để làm gì? Please select how you would like to receive your BASAGLAR savings card. an allergy to Basaglar or any of its ingredients. For more information, please see Full Prescribing Information, Patient Information and Instructions for Use. Abasaglar este un medicament care conţine substanţa activă insulină glargin. Transitioning Tell your doctor if you have any side effects. This site is intended for US HealthCare Professionals only. Basaglar = Basaglar® (insulin glargine injection) 100 units/mL; Click here. Please locate your BASAGLAR savings card and enter the following information. 3.1.16 03/2021 | GLOOTH00001 04/2015 Questions about Coronavirus? Change (rotate) where you inject your insulin with each dose. Priming ensures the Pen is ready to dose and removes air that may collect in the needle and cartridge during normal use. mix Basaglar with any other type of insulin or solution. Patient is responsible for any applicable taxes, fees, or amounts exceeding monthly or annual caps. BASAGLAR® and KwikPen® are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates and is available by prescription only. The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Toujeo = Toujeo® (insulin glargine injection) 300 units/mL. Twitter. DO NOT use insulin that has been frozen. (insulin glargine injection), for subcutaneous use, Lilly. Abasaglar is available as a 3-mL prefilled disposable pen (KwikPen ®) containing 300 units of insulin glargine . Facebook Product names listed above are trademarks or registered trademarks owned by or licensed to Eli Lilly and Company, its subsidiaries, or affiliates, BASAGLAR® (insulin glargine injection): Transitioning From Basal Insulin. SELECT SAFETY INFORMATIONWarningsDo not change the insulin you use or your dose, unless your doctor tells you to. The dose regimen (dose and timing) should be individually adjusted. Insulin should be kept away from direct heat and sunlight. All rights reserved. Contact Lilly. Insulina de substitutie actioneaza in acelasi mod ca insulina produsa pe cale naturala si ajuta glucoza sa treaca din sange in celulele organismului. Lantus® is a registered trademark of sanofi-aventis U.S. LLC. Insulin Storage Notes: 1. It is used in adults and children over the age of two for the treatment of diabetes. This website uses cookies and other technologies to personalize content and ads on this and other websites and provide social media features. All rights reserved. ABASAGLAR contains insulin glargine, an insulin analogue and has a prolonged duration of action. units of NPH insulin every morning and 25 units of NPH insulin Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Abasaglar is a basal insulin for once daily use and is bioequivalent to insulin glargine (Lantus). Click “Continue” to leave site or “Return to basaglar.com” to close this window and return to basaglar.com. TRICARE® is a registered trademark of the Department of Defense (DoD), DHA. ABASAGLAR contiene insulina glargine, un analogo dell'insulina, e ha una durata d'azione prolungata. units of Toujeo transitions to 40 units of Basaglar. Abasaglar seems like an odd name but look closer – ‘A -Basal-Glargine’. https://www.niddk.nih.gov/health-information/diabetes/overview/tests-diagnosis/a1c-test. Toujeo and Abasaglar for diabetes NTAG Northern Treatment Advisory Group, November 2015 2 Summary Toujeo® uses the same insulin glargine molecule as Lantus®, but is a higher- strength formulation (300 units/mL), than the existing insulin glargine product on Then your card will be ready to be shared with your specialty pharmacy. Subject to additional terms and conditions, which can be found at www.basaglar.com/support/savings. It is also known as insulin glargine injection. Please confirm below. Card activation is required. This can happen even if you change the needle. The patent for Lantus® (Insulin glargine) has expired and a biosimilar preparation called Abasaglar®, which has a lower cost, has been launched. SELECT SAFETY INFORMATIONWarningsDo not reuse needles or share your Basaglar prefilled pen with other people. Basaglar may cause serious side effects. Transitioning To download a savings card, just answer the following eligibility questions. Basaglar [package insert]. Unopened insulin vials and pens should be stored in a refrigerator at 36° F to 46°F and are good until expiration date This summary provides basic information about Basaglar but does not include all information known about this medicine. INDICATION Basaglar is a long-acting insulin that is only available with a prescription. This information is provided in response to your request. Posologia ABASAGLAR contiene insulina glargine, un analogo dell’insulina, e ha una durata d’azione prolungata. Tell your doctor:  about all of the medicines you take, including over-the-counter medicines, vitamins, and herbal supplements. Do not reuse needles or share your Basaglar prefilled pen with other people. units of Lantus transitions to 50 units of Basaglar, 50 Abasria (LY2963016) was submitted as a biosimilar, with Lantus (insulin glargine [rDNA origin] injection) as the chosen reference medicina l product. If your doctor decides to give your child Basaglar, he or she may give you special instructions. Some of these can lead to death. If you have heart failure, it may get worse while you take TZDs with Basaglar. LIMITATION OF USE Basaglar is not used to treat diabetic ketoacidosis. Eligible patients with commercial drug insurance may receive their BASAGLAR for as little as $5/month per prescription thanks to the BASAGLAR Savings Card.*.